Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Diana A. Villegas-Osorno"'
Autor:
Daniela Shveid-Gerson, Alejandro Noguez-Ramos, Diana A. Villegas-Osorno, Efraín I. Camarín-Sánchez, Lorena López-Zepeda, Christian P. Camacho-Limas, Alberto Villalobos-Prieto, J. Alberto Serrano-Olvera, Raquel Gerson-Cwilich
Publikováno v:
Revista Médica del Hospital General de México, Vol 84, Iss 4 (2021)
Introduction: The coronavirus disease 2019 (COVID-19) pandemic is a worldwide challenge. There are few reports regarding its behavior in cancer patients. Materials and methods: Retrospective study including cancer patients with severe acute respirato
Externí odkaz:
https://doaj.org/article/f4069bbf268849f5b142b4f142c30103
Autor:
Raquel Gerson-Cwilich, Daniela Shveid-Gerson, Alejandro Noguez-Ramos, Lorena López-Zepeda, Benigno E. Rodríguez-Soto, Diana A. Villegas-Osorno, Benjamín Valente-Acosta, Javier García-Guerrero, Francisco Moreno-Sánchez
Publikováno v:
Revista Médica del Hospital General de México, Vol 84, Iss 2 (2021)
Introduction: The Coronavirus disease (COVID-19) pandemic is a worldwide challenge. There are few useful tools to predict patient outcomes. Identification of biomarkers able to predict progression of the disease could improve the treatment of these p
Externí odkaz:
https://doaj.org/article/9d712971ba74484f81a0d52ef42a24cb
Autor:
María G. C. Navarrete-Bernal, Mayte G. Cervantes-Badillo, Jose Fabián Martínez-Herrera, César O. Lara-Torres, Raquel Gerson-Cwilich, Alejandro Zentella-Dehesa, María de Jesús Ibarra-Sánchez, José Esparza-López, Juan J. Montesinos, Víctor Adrián Cortés-Morales, Diego Osorio-Pérez, Diana A. Villegas-Osorno, Eduardo Reyes-Sánchez, Pablo Salazar-Sojo, Luis F. Tallabs-Utrilla, Sandra Romero-Córdoba, Leticia Rocha-Zavaleta
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Patients with triple-negative breast cancer (TNBC) have a poor prognosis, partly because of the absence of targeted therapies. Recognition of the key role of immune responses against cancer has allowed the advent of immunotherapy, focused on the inhi
Externí odkaz:
https://doaj.org/article/f15f17fd5d6c4186a7abe754e5cbd50e
Autor:
Saraí G De León-Rodríguez, Cristina Aguilar-Flores, Julián A Gajón, Ángel Juárez-Flores, Alejandra Mantilla, Raquel Gerson-Cwilich, José Fabián Martínez-Herrera, Diana Alejandra Villegas-Osorno, Claudia T Gutiérrez-Quiroz, Sergio Buenaventura-Cisneros, Mario Alberto Sánchez-Prieto, Edmundo Castelán-Maldonado, Samuel Rivera Rivera, Ezequiel M Fuentes-Pananá, Laura C Bonifaz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Melanoma, the most lethal form of skin cancer, has undergone a transformative treatment shift with the advent of checkpoint blockade immunotherapy (CBI). Understanding the intricate network of immune cells infiltrating the tumor and orches
Externí odkaz:
https://doaj.org/article/8ab5aa2af15e4a039c6dff460d7a7344
Autor:
Raquel Gerson Cwilich, Alejandro Zentella Dehesa, Héctor Murrieta González, Laura Daniela Campos Alvarado, Eric Alejandro García López, Christian Patricio Camacho Limas, Gabriela Olivia Regalado Porras, Jesús Miguel Lázaro León, Guillermo Manuel Olivares Beltrán, Juan Alberto Serrano Olvera, Alberto Villalobos Prieto, Diana Alejandra Villegas Osorno, Daniela Shveid Gerson, Alejandro Noguez Ramos
Publikováno v:
Anales Médicos de la Asociación Médica del Centro Médico ABC. 66:238-248
Autor:
Raquel Gerson-Cwilich, Christian Patricio Camacho-Limas, J. Alberto Serrano-Olvera, Lorena López-Zepeda, Diana A. Villegas-Osorno, Alejandro Noguez-Ramos, Daniela Shveid-Gerson, Efraín I. Camarín-Sánchez, Alberto Villalobos-Prieto
Publikováno v:
Revista Médica del Hospital General de México, Vol 84, Iss 4 (2021)
Introduction: The coronavirus disease 2019 (COVID-19) pandemic is a worldwide challenge. There are few reports regarding its behavior in cancer patients. Materials and methods: Retrospective study including cancer patients with severe acute respirato
Autor:
Francisco Moreno-Sanchez, Benigno E. Rodríguez-Soto, Raquel Gerson-Cwilich, Daniela Shveid-Gerson, Diana A. Villegas-Osorno, Alejandro Noguez-Ramos, Lorena López-Zepeda, Javier Garcia-Guerrero, Benjamín Valente-Acosta
Publikováno v:
Revista Médica del Hospital General de México, Vol 84, Iss 2 (2021)
Introduction: The Coronavirus disease (COVID-19) pandemic is a worldwide challenge. There are few useful tools to predict patient outcomes. Identification of biomarkers able to predict progression of the disease could improve the treatment of these p
Autor:
Omar Serrano Villamayor, Geovani Amador, Raul Alejandro Andrade Moreno, Alejandro Noguez-Ramos, Raquel Gerson Cwilich, Guillermo Olivares, Alberto Villalobos, Christian Patricio Camacho Limas, José Fabián Martínez-Herrera, Lorena López Zepeda, Benigno Rodriguez, Diana Alejandra Villegas Osorno, Ervin Saúl Enciso López, Efrain Isaias Camarin Sanchez, Daniela Shveid Gerson, Cecilia Nehmad, Daniela Vazquez Juarez, Juan Manuel Tovar Cabrera, Diana Bonilla Molina, Juan Alberto Serrano
Publikováno v:
Journal of Clinical Oncology. 40:e22517-e22517
e22517 Background: there are few reported series n women with breast cancer (BC) and COVID-19, a better prognosis has been observed, with a lower rate of hospitalization and mortality than other neoplasms. Methods: We conducted a restrospective, non-
Autor:
Benigno Rodriguez, Efrain Isaias Camarin Sanchez, Alberto Villalobos, Diana Alejandra Villegas Osorno, Omar Serrano Villamayor, Daniela Shveid Gerson, Gabriela Olivia Regalado Porras, Raquel Gerson, Lorena López Zepeda, Guillermo Olivares, Ervin Saúl Enciso López, José Fabián Martínez-Herrera
Publikováno v:
Journal of Clinical Oncology. 39:e16105-e16105
e16105 Background: Gastric cancer (GC) and gastroesophageal junction cancer (GEJ) are the second most prevalent and lethal digestive malignancies worldwide. According to GLOBOCAN 2020, the incidence in Mexican population is 4.5% and represents 7% of
Autor:
Alejandro Noguez-Ramos, Daniela Vazquez Juarez, Guillermo Olivares, Efrain Isaias Camarin Sanchez, Omar Serrano Villamayor, Raul Alejandro Andrade Moreno, Geovani Amador, Benigno Rodriguez, Alberto Villalobos, Daniela Shveid Gerson, Raquel Gerson, Lorena López Zepeda, Diana Alejandra Villegas Osorno, José Fabián Martínez-Herrera, Ervin Saúl Enciso López
Publikováno v:
Journal of Clinical Oncology. 39:e20565-e20565
e20565 Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer. Prognosis is generally poor, with a median overall survival (mOS) of approximately 12 months. MPM appears to be directly linked to immunosuppressive mechanisms,